Data / Drug companies / Guangzhou Meijiao Medical Biotechnology Co., Ltd.
Guangzhou Meijiao Medical Biotechnology Co., Ltd.: 13 products in the FDA NDC directory, labeler code 87036
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guangzhou Meijiao Medical Biotechnology Co., Ltd. (labeler code 87036) lists 13 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 13 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 8, 2026.
The request: Watch Guangzhou Meijiao Medical Biotechnology Co., Ltd. (FDA labeler code 87036): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 87036
- Products in commercial distribution
- 13
- Packages
- 13
- Finished drugs by generic name
- 8
- Prescription products
- 0
- Over the counter products
- 13
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- August 17, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 13 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Zinc oxide,titanium dioxide | 2 | 2 |
| Titanium dioxide | 2 | 51 |
| Rh-oligopeptide-1 | 2 | 1 |
| Salicylic acid | 2 | 330 |
| Tremella fuciformis whole | 1 | 1 |
| Palmitoyl tripeptide-8 | 1 | 1 |
| Ceramide np | 1 | 2 |
| Dendrobium officinale stem | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 7 | 53.8% |
| Liquid | 5 | 38.5% |
| Spray | 1 | 7.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| FermaGlow Sunscreen SPF 50 | 87036-037 | Cream | Over the counter monograph drugs | January 8, 2026 |
| ODLUMIVIE Tinted Mineral Sunscreen | 87036-036 | Cream | Over the counter monograph drugs | January 8, 2026 |
| FermaGlow Instant Anti Aging Wrinkle Eye Treatment Syringe | 87036-040 | Cream | Over the counter monograph drugs | November 18, 2025 |
| Sandra Plasencia Dendrobium Officinale Soothing Biofermented Mask | 87036-025 | Liquid | Over the counter monograph drugs | September 24, 2025 |
| ODLUMIVIE Dendrobium Restorative Mask | 87036-030 | Liquid | Over the counter monograph drugs | September 2, 2025 |
| ODLUMIVIE Ceramide ReviCell Cream | 87036-029 | Cream | Over the counter monograph drugs | September 2, 2025 |
| ODLUMIVIE Salmon DNA Repairing Serum | 87036-028 | Liquid | Over the counter monograph drugs | September 2, 2025 |
| ODLUMIVIE Peptide CalmMist | 87036-027 | Spray | Over the counter monograph drugs | September 2, 2025 |
| ODLUMIVIE Tremella Revitalizing Cleanser | 87036-026 | Liquid | Over the counter monograph drugs | September 2, 2025 |
| Sandra Plasencia PDRN Rejuvenating Serum | 87036-035 | Liquid | Over the counter monograph drugs | August 23, 2025 |
| CAVOREAL Plus Salicylic Acid Anti Acne with BHA HA | 87036-033 | Cream | Over the counter monograph drugs | August 21, 2025 |
| CAVOREAL Plus Salicylic Acid Anti Acne with BHA HA | 87036-032 | Cream | Over the counter monograph drugs | August 17, 2025 |
| Sandra Plasencia Green Tea Daily SPF 50 Moisturizer | 87036-031 | Cream | Over the counter monograph drugs | August 17, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.